Determination of diphtheria risk indicators based on the study of antidiphtheria immunity in the population of Dnipropetrovsk region


  • І.V. Budaieva Dnipro State Medical University, Dnipro, Ukraine, Ukraine
  • H.О. Revenko Dnipro State Medical University, Dnipro, Ukraine, Ukraine
  • V.V. Маvrutenkov Dnipro State Medical University, Dnipro, Ukraine, Ukraine
  • О.P. Shtepa Dnipro State Medical University, Dnipro, Ukraine, Ukraine
  • V.H. Rezvykh SI “Dnipropetrovsk Oblast Center for Diseases Control and Prevention of the Ministry of Health of Ukraine”, Dnipro, Ukraine, Ukraine
  • О.V. Kuzmenko SI “Dnipropetrovsk Oblast Center for Diseases Control and Prevention of the Ministry of Health of Ukraine”, Dnipro, Ukraine, Ukraine
  • I.P. Belova SI “Dnipropetrovsk Oblast Center for Diseases Control and Prevention of the Ministry of Health of Ukraine”, Dnipro, Ukraine, Ukraine



population immunity, diphtheria, vaccination, antibodies


Background. Vaccination is the most effective part of primary prevention. Serological monitoring of infectious diseases covered by national immunization programs is very important as it provides up-to-date information on the burden of the infection and the immunological status of the population. The study was aimed to present an analysis of epidemiological monitoring of the protection against diphtheria of the population, to show the generalized epidemiological situation regarding diphtheria, and to determine the risk of diphtheria among the population of Dnipropetrovsk region. Materials and methods. Epidemiological analysis of diphtheria immunity (2017–2019) was performed based on the results of enzyme-linked immunosorbent assay of IgG antibodies levels against diphtheria toxin in 271 residents of Dnipropetrovsk region. Results. Analysis of the results revealed that only 30.6 % (n = 83) of the population have levels of antitoxic antibodies of 1.0 IU/ml or more, which provides sufficient protection against diphtheria in the next 5–7 years of life. At that time, the majority of the population (69.4 %) needs immediate one-time booster vaccination (n = 134; 49.5 %) or immediate basic vaccination (n = 54; 19.9 %) due to low levels of antitoxic diphtheria antibodies. In the age group 8–15 years, 65.9 % (n = 62) of patients require immediate basic or booster vaccination, which indicates that children of this age do not have basic immunological protection due to violations of the vaccination schedule or its absence. In the group aged 27 years and older, 79.1 % (n = 72) of the subjects do not have protective levels of anti-diphtheria antibodies, which indicates a lack of actual protection against diphtheria. Conclusions. The results indicate insufficient protection of the population against diphtheria. In this regard, the development of strategic measures for mass immunoprophylaxis of diphtheria both in children and adults is relevant. The country should conduct regular epidemiological monitoring, which would study the population’s immunity against diphtheria and other controlled infections, and draw up a long-term strategic and tactical plan to address shortcomings in the work of mass immunoprophylaxis of the population.


Global Health Risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization (WHO), 2009. 62 p.

Ревенко Г.О., Будаєва І.В., Маврутенков В.В. Серологічний моніторинг популяційного антитоксичного протидифтерійного імунітету в мешканців Дніпропетровської області. Клінічна та профілактична медицина. 2019. 4(9–10). 128-133.

Kutty J.M., RajanBabu B., Thiruvoth S. Immune status against diphtheria in healthy adults. J. Family Med. Prim. Care. 2019. 8(10). 3253-3257. doi: 10.4103/jfmpc.jfmpc_589_19.

Weinberger B. Vaccination of Adults and the Older Population against Tetanus, Diphtheria, Pertussis, and Tick-Borne Encephalitis: The Importance of Booster Vaccinations throughout Life. Interdiscip. Top. Gerontol. Geriatr. 2020. 43. 146-157. doi: 10.1159/000504489.

Frasca D. Senescent B cells in aging and age-related diseases: their role in the regulation of antibody responses. Exp. Gerontol. 2018. 107. 55-58. doi: 10.1016/j.exger.2017.07.002.

Grasse M., Meryk A., Schirmer M., Grubeck-Loebenstein B., Weinberger B. Booster vaccination against tetanus and diphtheria: insufficient protection against diphtheria in young and elderly adults. Immun. Ageing. 2016. 13(1). 26. doi: 10.1186/s12979-016-0081-0.

Revenko H.О., Мavrutenkov V.V., Chykarenko Z.О. Clinical and laboratory predictors of antitoxic immunity against diphtheria and tetanus in adults with HIV infection. Medicni perspektivi. 2020. 25(3). 117-124.

Hammarlund E., Thomas A., Poore E.A., Amanna I.A., Rynko A.E., Mori M., Chen Z., Slifka M.K. Durability of Vaccine-Induced Immunity Against Tetanus and Diphtheria Toxins: A Cross-sectional Analysis. Clin. Infect. Dis. 2016. 62(9). 1111-1118. doi: 10.1093/cid/ciw066.

Liang J.L., Tiwari T., Moro P., Messonnier N.E., Reingold A., Sawyer M., Clark T.A. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2018. 67(2). 1-44. doi: 10.15585/mmwr.rr6702a1.

Swart E.M., van Gageldonk P.G.M., de Melker H.E., van der Klis F.R., Berbers G.A.M., Mollema L. Long-term protection against diphtheria in the Netherlands after 50 years of vaccination: results from a seroepidemiological study. PLoS One. 2016. 11(2). e0148605. doi: 10.1371/journal.pone.0148605.

Yao N., Zeng Q., Wang Q. Seroepidemiology of diphtheria and pertussis in Chongqing, China: serology-based evidence of Bordetella pertussis infection. Public Health. 2018. 156. 60-66. doi: 10.1016/j.puhe.2017.12.00.

Маврутенков В.В., Ревенко Г.О. Вакцинопрофілактика: досягнення, проблеми і перспективи розвитку. Медичні перспективи. 2016. 21(3). 56-61. DOI: 10.26641/2307-0404.2016.3.82025.

Public Health Center of the Ministry of Health of Ukraine [Internet]. Available online:

Bonanni P., Bonaccorsi G., Lorini C., Santomauro F., Tis­cione E., Boccalini S., Bechini A. Focusing on the implementation of 21st century vaccines for adults. Vaccine. 2018. 36(36). 5358-5365. doi: 10.1016/j.vaccine.2017.07.100.

Gower C.M., Scobie A., Fry N.K., Litt D.J., Cameron J.C., Chand M.A., Brown C.S., Collins S., White J.M., Ramsay M.E., Amirthalingam G. The changing epidemiology of diphtheria in the United Kingdom, 2009 to 2017. Eurosurveillance. 25(11). 1900462. doi: 10.2807/1560-7917.ES.2020.25.11.1900462.

Berbers G., van Gageldonk P., van de Kassteele J., Wiedermann U., Desombere I., Dalby T., Toubiana J., Tsiodras S., Fe­rencz I.P., Mullan K., Griskevicius A., Kolupajeva T., Vestrheim D.F., Palminha P., Popovici O., Wehlin L., Kastrin T., Maďarová L., Campbell H., Ködmön C., Bacci S., Barkoff A.M., He Q. Circulation of pertussis and poor protictio against diphtheria among middle-aged adults in 18 European countries. 2021. 12. 2871. doi: 10.21203/

Jablonka A., Behrens G.M., Stange M., Dopfer C., Grote U., Hansen G., Schmidt R.E., Happle C. Tetanus and diphtheria immunity in refugees in Europe in 2015. Infection. 2017. 45(2). 157-164. doi: 10.1007/s15010-016-0934-7.





Original Researches